ArticleJournal of pharmaceutical policy and practice2024

Trends in prescription and cost of Sativex, a cannabinoid-based medicine, in treating patients with multiple sclerosis in England.

Farideh A Javid et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.